CV Sciences, Inc. (CVSI)
OQB · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About CV Sciences, Inc.
CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 3.6M | 3.3M | 3.3M | 3.2M |
| Gross Profit | 1.8M | 1.6M | 1.7M | 1.6M |
| Operating Income | -131K | -275K | -75K | -318K |
| Net Income | -261K | -382K | -206K | -643K |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 16.2M | 16.0M | 15.7M | 13.8M |
| Gross Profit | 5.5M | 7.1M | 7.2M | 6.8M |
| Operating Income | -6.8M | 3.4M | -2.2M | -470K |
| Net Income | -8.2M | 3.1M | -2.4M | -958K |
| Diluted EPS | $-0.07 | $0.02 | $-0.01 | $-0.01 |